Sign, sign, everywhere a vaccine sign…
A new study published in the journal Clinical Infectious Diseases actually claims taking antidepressants will increase vaccine effectiveness.
The two-year study compared immune responses in 40 elderly participants with major depressive disorder to 52 control subjects in regard to Merck’s Zostavax, the herpes zoster (shingles) vaccine. According to an Infectious Diseases Society of America press release:
“Depressed patients not being treated with antidepressants (selective serotonin reuptake inhibitors) had lower cell-mediated immunity to the varicella-zoster virus—and were less able to respond to the shingles vaccine—compared with patients who were not depressed or who were depressed but were receiving treatment with antidepressants, the researchers found.”
The implications here are much more frightening, as the press release continued:
“The possible connection, however, is potentially significant: If antidepressants increase the efficacy of the shingles vaccine in those who are depressed, such treatment may have a similar effect on the immune response of depressed patients to other important vaccines, such those against influenza.”
So, let’s get this straight: it isn’t the ineffectual vaccines themselves we should be concerned with, it’s the fact that, if we get depressed, we all need to take antidepressant medications in order to make our vaccines work better?
As it stands, America consumes more psychotropic drugs than any other country in the world, a fact surely not missed by pharmaceutical companies. In fact, antidepressants were recently named the nation’s number one prescription for adults aged 18-44.
Big Pharma giant Merck & Co. is currently responsible for the production of nine vaccines, including the ‘live vaccine’ Zostavax for shingles. But what’s more, while the mainstream media is readily reporting that untreated depression is hurting vaccine efficacy in the study’s wake, many forgot to mention that, of the 20 authors listed on this study, four of them work for guess who?